Dear Friends:
Over the past few days, David’s health has declined. At this point, the Lubitz family has decided to only have immediate family members visit with David. Thank you for understanding and respecting their wishes.
This past weekend David was admitted to the hospital at NIH. He completed his first two treatments as part of the clinic trial with minimal complications. However, after the third treatment he began to experience severe side effects coupled with decreasing sodium levels (similar to what happened in December). David is still in the hospital […]
David returned home from the hospital within hours of posting the December 23rd update. Since then, he was accepted at a clinical trial at NIH, and started treatment on January 6th. The trial includes chemotherapy and PARP inhibiters. The chemotherapy consists of one 5-hour treatment every two weeks, and the PARP inhibitors are taken orally […]